Ketamine and suicidal behavior : Contribution of animal models of aggression-impulsivity to understanding its mechanism of action
Copyright © 2023. Published by Elsevier Masson SAS..
More than two-thirds of suicides occur during a major depressive episode. Acting out prevention measures and therapeutic options to manage the suicidal crisis are limited. The impulsive-aggressive dimensions are vulnerability factors associated with suicide in patients suffering from a characterized depressive episode: this can be a dimension involved in animals. Impulsive and aggressive rodent models can help analyze, at least in part, the neurobiology of suicide and the beneficial effects of treatments. Ketamine, a glutamatergic antagonist, by rapidly improving the symptoms of depressive episodes, would help reduce suicidal thoughts in the short term. Animal models share with humans impulsive and aggressive endophenotypes modulated by the serotonergic system (5-HTB receptor, MAO-A enzyme), neuroinflammation or the hypothalamic-pituitary-adrenal axis and stress. Significant effects of ketamine on these endophenotypes remain to be demonstrated.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
|---|---|
| Enthalten in: |
Annales pharmaceutiques francaises - 82(2024), 1 vom: 08. Jan., Seite 3-14 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Kétamine et suicidalité : modèles animaux pour comprendre son mécanisme d’action |
|---|
| Beteiligte Personen: |
Nguyen, Thi Mai Loan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
690G0D6V8H |
|---|
| Anmerkungen: |
Date Completed 08.01.2024 Date Revised 08.01.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.pharma.2023.10.008 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363827773 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363827773 | ||
| 003 | DE-627 | ||
| 005 | 20240114232005.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.pharma.2023.10.008 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1252.xml |
| 035 | |a (DE-627)NLM363827773 | ||
| 035 | |a (NLM)37890717 | ||
| 035 | |a (PII)S0003-4509(23)00133-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Nguyen, Thi Mai Loan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ketamine and suicidal behavior |b Contribution of animal models of aggression-impulsivity to understanding its mechanism of action |
| 246 | 3 | 3 | |a Kétamine et suicidalité : modèles animaux pour comprendre son mécanisme d’action |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.01.2024 | ||
| 500 | |a Date Revised 08.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023. Published by Elsevier Masson SAS. | ||
| 520 | |a More than two-thirds of suicides occur during a major depressive episode. Acting out prevention measures and therapeutic options to manage the suicidal crisis are limited. The impulsive-aggressive dimensions are vulnerability factors associated with suicide in patients suffering from a characterized depressive episode: this can be a dimension involved in animals. Impulsive and aggressive rodent models can help analyze, at least in part, the neurobiology of suicide and the beneficial effects of treatments. Ketamine, a glutamatergic antagonist, by rapidly improving the symptoms of depressive episodes, would help reduce suicidal thoughts in the short term. Animal models share with humans impulsive and aggressive endophenotypes modulated by the serotonergic system (5-HTB receptor, MAO-A enzyme), neuroinflammation or the hypothalamic-pituitary-adrenal axis and stress. Significant effects of ketamine on these endophenotypes remain to be demonstrated | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Aggression | |
| 650 | 4 | |a Agressivité | |
| 650 | 4 | |a Animal models | |
| 650 | 4 | |a Antidepressant | |
| 650 | 4 | |a Antidépresseur | |
| 650 | 4 | |a Impulsivity | |
| 650 | 4 | |a Impulsivité | |
| 650 | 4 | |a Ketamine | |
| 650 | 4 | |a Kétamine | |
| 650 | 4 | |a Modèles animaux | |
| 650 | 4 | |a Suicide | |
| 650 | 7 | |a Ketamine |2 NLM | |
| 650 | 7 | |a 690G0D6V8H |2 NLM | |
| 700 | 1 | |a Jollant, Fabrice |e verfasserin |4 aut | |
| 700 | 1 | |a Tritschler, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Colle, Romain |e verfasserin |4 aut | |
| 700 | 1 | |a Corruble, Emmanuelle |e verfasserin |4 aut | |
| 700 | 1 | |a Gardier, Alain M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annales pharmaceutiques francaises |d 1945 |g 82(2024), 1 vom: 08. Jan., Seite 3-14 |w (DE-627)NLM000046493 |x 0003-4509 |7 nnns |
| 773 | 1 | 8 | |g volume:82 |g year:2024 |g number:1 |g day:08 |g month:01 |g pages:3-14 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.pharma.2023.10.008 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 82 |j 2024 |e 1 |b 08 |c 01 |h 3-14 | ||